Laparoscopic Ultrasound Guided Tissue Sampling in Patients With Cancer of the Upper Gastrointestinal Tract
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00511264|
Recruitment Status : Completed
First Posted : August 3, 2007
Last Update Posted : May 29, 2008
Laparoscopic Ultrasound (LUS) is an important part of the pre-treatment evaluation of patients with upper gastrointestinal tract cancer (esophageal, gastric, pancreatic and liver cancer). When a suspect lesion is visualized during LUS a biopsy should be provided in order to differentiate between benign and malignant lesions. A new system for LUS guided biopsy has been developed, but how often these biopsies are clinically relevant (i.e. changing patient management)and how reliable are these biopsies are unknown.
The study hypothesis is that LUS guided biopsies are accurate and clinically relevant in the pre-treatment evaluation of patients with upper gastrointestinal tract cancer.
|Condition or disease|
|Esophageal Cancer Gastric Cancer Pancreatic Cancer Liver Cancer|
|Study Type :||Observational|
|Estimated Enrollment :||250 participants|
|Official Title:||Prospective Evaluation of the Impact of Laparoscopic Ultrasound (LUS) Guided Fine-Needle Aspiration or Tru-Cut Biopsy in Patients With Upper GI Tract Cancer|
|Study Start Date :||May 2007|
|Actual Primary Completion Date :||May 2008|
|Actual Study Completion Date :||May 2008|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00511264
|Department of Surgery, Odense University Hospital|
|Odense, Denmark, 5000|
|Principal Investigator:||Michael B Mortensen, MD, Ph.D.||Department of Surgery, Odense University Hospital|